biote Corp. (BTMD)

US — Healthcare Sector
Peers: ADUS  BICX  CMRA  DRTS  EHAB  GROV 

Automate Your Wheel Strategy on BTMD

With Tiblio's Option Bot, you can configure your own wheel strategy including BTMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol BTMD
  • Rev/Share 6.3086
  • Book/Share -2.4984
  • PB -1.2008
  • Debt/Equity -1.3685
  • CurrentRatio 0.9796
  • ROIC 0.5454

 

  • MktCap 143553906.0
  • FreeCF/Share 1.1086
  • PFCF 4.1034
  • PE 3.0238
  • Debt/Assets 1.0295
  • DivYield 0
  • ROE -0.3119

 

  • Rating B-
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade BTMD B. Riley Securities Buy Neutral -- $4 Aug. 7, 2025
Initiation BTMD Craig Hallum -- Buy -- -- Dec. 16, 2024

News

Is biote Corp. (BTMD) Stock Undervalued Right Now?
BTMD
Published: July 08, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Is biote Corp. (BTMD) Stock Undervalued Right Now?
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates
BTMD
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Biote Corp. (BTMD) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.23 per share a year ago.

Read More
image for news Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates

About biote Corp. (BTMD)

  • IPO Date 2021-04-28
  • Website https://biote.com
  • Industry Medical - Care Facilities
  • CEO Bret Christensen
  • Employees 217
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.